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Originally considered a marker of hematopoietic stem cells, CD133/prominin is 
a highly glycosylated trans-membrane protein expressed in various tissues, such as 
breast, in which it seems to regulate ductal branching but not regenerative capacity [1].
CD133 is also expressed in various solid tumors, including breast cancer, in 
which CD133-positivity seems to identify a restricted subgroup of tumor stem cells 
[2]. CD133 expression was heterogeneous in different breast carcinomas but, in tri-
ple-negative (ER-, PR-, HER2-) invasive ductal breast carcinoma, CD133 correlates 
with tumor size, metastasis and clinical stage [3]. 
In order to establish a correlation between the surface recognition of CD133 and 
the phenotype of tumor cells, the highly invasive breast-derived MDA-MB-231 cells 
(ER-, PR-, HER2-) were subjected to immunomagnetic separation of CD133+ and 
CD133- subpopulations, which were analyzed for malignant properties. In compari-
son to CD133- cells, the expression of CD133 characterizes cells with a larger adhe-
sion area, lower proliferation rate and reduced migration speed. This phenotype cor-
relates with altered expression of malignancy-associated proteins and with a peculiar 
pattern of PLC, in turn involved in proliferation and motility of breast tumor cells 
(4-6). This suggests that, in triple negative ductal breast tumor-derived cells, the 
expression of CD133 characterizes a small subset of cells with a less undifferentiat-
ed phenotype. The reduced expression of CD133 at membrane level may constitute 
a marker of the switch of tumor cells from a less malignant to a mature phenotype 
since it correlates with the de-regulation of proteins involved in cell proliferation, 
motility and invasion.
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